- Home
- SARO vs ROIV Comparison
SARO vs ROIV Comparison
Compare SARO & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SARO
- ROIV
- Stock Information
- Founded
- SARO 1911
- ROIV 2014
- Country
- SARO United States
- ROIV United Kingdom
- Employees
- SARO N/A
- ROIV N/A
- Industry
- SARO
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- SARO
- ROIV Health Care
- Exchange
- SARO NYSE
- ROIV Nasdaq
- Market Cap
- SARO 9.3B
- ROIV 8.4B
- IPO Year
- SARO 2024
- ROIV N/A
- Fundamental
- Price
- SARO $28.16
- ROIV $10.87
- Analyst Decision
- SARO Buy
- ROIV Buy
- Analyst Count
- SARO 8
- ROIV 4
- Target Price
- SARO $34.75
- ROIV $17.50
- AVG Volume (30 Days)
- SARO 2.7M
- ROIV 5.2M
- Earning Date
- SARO 05-12-2025
- ROIV 05-29-2025
- Dividend Yield
- SARO N/A
- ROIV N/A
- EPS Growth
- SARO N/A
- ROIV N/A
- EPS
- SARO 0.23
- ROIV N/A
- Revenue
- SARO $5,437,026,000.00
- ROIV $122,585,000.00
- Revenue This Year
- SARO $15.54
- ROIV N/A
- Revenue Next Year
- SARO $11.37
- ROIV N/A
- P/E Ratio
- SARO $120.17
- ROIV N/A
- Revenue Growth
- SARO 17.03
- ROIV 140.04
- 52 Week Low
- SARO $21.31
- ROIV $8.73
- 52 Week High
- SARO $34.38
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- SARO N/A
- ROIV 51.00
- Support Level
- SARO N/A
- ROIV $10.58
- Resistance Level
- SARO N/A
- ROIV $11.07
- Average True Range (ATR)
- SARO 0.00
- ROIV 0.30
- MACD
- SARO 0.00
- ROIV -0.04
- Stochastic Oscillator
- SARO 0.00
- ROIV 30.21
About SARO STANDARDAERO INC.
StandardAero Inc is a provider of aftermarket services for fixed and rotary wing aircraft gas turbine engines and auxiliary power units (APUs) to the commercial, business, and military aircraft markets. It also provides aftermarket and upgrade services for business aviation and helicopter airframes and avionics. It operates in two segments Engine Services and Component Repair Services. The group generates the majority of its revenue from the Engine Services segment which provides engine and airframe maintenance, repair, overhaul, and related services to customers in the Commercial Aerospace, Military & Helicopter, and Business Aviation end markets.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.